More on GlaxoSmithKline (GSK +0.1%) Q3: Ups dividend by 6% to £0.18. Expects sales growth in Q4,...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor

More on GlaxoSmithKline (GSK +0.1%) Q3: Ups dividend by 6% to £0.18. Expects sales growth in Q4, in particular with further momentum in emerging markets and Asia Pacific, and for core operating margin in 2012 to be broadly in line with last year. (PR)